drugset / Trial / NCT06719544
A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)
Non-randomizedCrossoverOpen-labelBasic science
Summary
Researchers have designed a new study medicine called enlicitide decanoate (MK-0616) as a new way to lower the amount of low-density lipoprotein cholesterol (LDL-C) in a person's blood. Enlicitide decanoate will be called "enlicitide" from this point forward. Lithium (also called lithium carbonate) is a medicine used in bipolar disorder. Researchers want to learn about lithium when taken at the same time with enlicitide. They want to: * Measure a person's blood to find out if the amount of lithium in the blood is the same when lithium is taken alone or with enlicitide * Learn about the safety of lithium when taken alone or with enlicitide and if people tolerate it
Timeline
- Start
- 2025-01-02
- Primary completion
- 2025-01-27
- Completion
- 2025-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enlicitide | Unknown | — | Oral |
| Subject | Lithium Carbonate | Unknown | — | Oral |
Indications
No indication recorded.